by Paul Winner | Sep 18, 2019 | Migraines
A novel treatment option for acute migraine that is currently under review by the Food and Drug Administration (FDA) has shown promising results in the reduction of pain and disability in acute migraine sufferers. The drug ubrogepant, developed by Allergen, is a small...
by Paul Winner | Jul 21, 2019 | Migraines
Over the past decade, there has been a significant amount of progress made in the development of new preventative migraine therapies that differ from previous treatment types. One such breakthrough was the recent FDA approval of medications in a novel class of drugs...
by Paul Winner | Mar 12, 2019 | Migraines
Most people who experience migraine headaches have a number of triggers which can kick-start an acute episode. By understanding what these triggers are, migraine sufferers can make lifestyle adjustments that can help to prevent or minimize the frequency and severity...
by Paul Winner | Jan 15, 2019 | Migraines
A new and unique class of preventive migraine treatments have been approved by the FDA over the past year which have several benefits over older medications for the prevention of migraine. Anti-CGRP medicines, which are monoclonal antibodies, block the activity of...
by Paul Winner | Dec 4, 2018 | Migraines
Today there are more treatment options available for people who suffer from migraine than ever before. As a result, people with migraine are now better able to manage their symptoms due to the variety of therapies available, whether through drug or non-drug...
by Paul Winner | Oct 25, 2018 | Migraines
Migraine and tension headaches are often painful, but there are notable differences between them that many people are unaware of. It is important to know what these differences are, as they can be pivotal in deciding to seek out a proper diagnosis and treatment. While...